Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biohaven’s Oral CGRP Inhibitor Nurtec ODT Approved In The US For Acute Migraine
Feb 28 2020
•
By
Mandy Jackson
Nurtec ODT is a fast-dissolving tablet designed for rapid migraine relief • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip